Replies to post #16424 on Momenta Pharmaceuticals, Inc. (MNTA)

[Bickema]

As a result there are very few big players that would likely be buyers (of MNTA) unless they drop or terminate existing biosimilar partnerships.

I still hold out hope that M923 could bring a buyout instead of a partnership.